IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+27.08%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$481M
AUM Growth
+$481M
(+121%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
48.2%
Top 10 Holdings %
Top 10 Hldgs %
40.64%
Holding
93
New
17
Increased
41
Reduced
5
Closed
21
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$20.2M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$18.4M |
| 3 |
Biogen
BIIB
|
$13.3M |
| 4 |
MDCO
Medicines Co
MDCO
|
$12.8M |
| 5 |
Amgen
AMGN
|
$12.5M |
Top Sells
| 1 |
Baxter International
BAX
|
$6.11M |
| 2 |
HCA Healthcare
HCA
|
$3.85M |
| 3 |
Illumina
ILMN
|
$3.51M |
| 4 |
Elevance Health
ELV
|
$2.51M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$2.1M |
Sector Composition
| 1 | Healthcare | 85.28% |
| 2 | Energy | 1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Minerva Neurosciences
NERV
$16.5M
| $6.35M | 1.13% |
450,000
+325,000
| +260% | +$4.59M |
|
|
27
Elevance Health
ELV
$71.8B
| $6.27M | 1.12% |
50,000
-20,000
| -29% | -$2.51M |
|
|
MDRX
28
DELISTED
Veradigm Inc. Common Stock
MDRX
| $5.93M | 1.06% |
450,000
+200,000
| +80% | +$2.63M |
|
|
KTWO
29
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.87M | 1.05% |
330,000
+190,000
| +136% | +$3.38M |
|
|
SPNC
30
DELISTED
Spectranetics Corp
SPNC
| $5.52M | 0.98% |
220,000
+110,000
| +100% | +$2.76M |
|
|
GWPH
31
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $5.31M | 0.95% |
+40,000
| New | +$5.31M |
|
32
Pacira BioSciences
PCRX
$1.2B
| $5.13M | 0.92% |
+150,000
| New | +$5.13M |
|
|
AVDL
33
Avadel Pharmaceuticals
AVDL
$1.43B
| $4.96M | 0.88% |
400,000
+325,000
| +433% | +$4.03M |
|
|
ALDR
34
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $4.92M | 0.88% |
+150,000
| New | +$4.92M |
|
|
LHCG
35
DELISTED
LHC Group LLC
LHCG
| $4.79M | 0.85% |
+130,000
| New | +$4.79M |
|
|
IPXL
36
DELISTED
Impax Laboratories, Inc.
IPXL
| $4.74M | 0.85% |
+200,000
| New | +$4.74M |
|
37
Travere Therapeutics
TVTX
$1.56B
| $4.48M | 0.8% |
+200,000
| New | +$4.48M |
|
38
Option Care Health
OPCH
$4.65B
| $4.34M | 0.77% |
1,500,000
+750,000
| +100% | +$2.17M |
|
|
PMC
39
DELISTED
PharMerica Corporation
PMC
| $4.21M | 0.75% |
150,000
+85,000
| +131% | +$2.39M |
|
|
AXDX
40
DELISTED
Accelerate Diagnostics
AXDX
| $4.09M | 0.73% |
150,000
| – | – |
|
41
Ionis Pharmaceuticals
IONS
$6.79B
| $3.66M | 0.65% |
+100,000
| New | +$3.66M |
|
42
Acadia Healthcare
ACHC
$2.12B
| $3.47M | 0.62% |
+70,000
| New | +$3.47M |
|
|
KITE
43
DELISTED
Kite Pharma, Inc.
KITE
| $3.35M | 0.6% |
60,000
+10,000
| +20% | +$559K |
|
|
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.23M | 0.58% |
+70,000
| New | +$3.23M |
|
45
Sarepta Therapeutics
SRPT
$1.78B
| $3.07M | 0.55% |
+50,000
| New | +$3.07M |
|
|
XENT
46
DELISTED
Intersect ENT, Inc
XENT
| $2.85M | 0.51% |
180,000
+30,000
| +20% | +$475K |
|
47
Tandem Diabetes Care
TNDM
$845M
| $2.83M | 0.51% |
370,000
+195,000
| +111% | +$1.49M |
|
|
IVTY
48
DELISTED
Invuity, Inc
IVTY
| $2.74M | 0.49% |
+200,000
| New | +$2.74M |
|
|
ARRY
49
DELISTED
Array Biopharma Inc
ARRY
| $2.7M | 0.48% |
+400,000
| New | +$2.7M |
|
50
Pacific Biosciences
PACB
$393M
| $2.69M | 0.48% |
300,000
+200,000
| +200% | +$1.79M |
|